These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4649767)

  • 21. Liver injury induced by 2-deoxy-D-galactose.
    Keppler DO; Hübner G
    Exp Mol Pathol; 1973 Dec; 19(3):365-77. PubMed ID: 4763635
    [No Abstract]   [Full Text] [Related]  

  • 22. Separation and analysis of 4'-epimeric UDP-sugars by borate high-performance liquid chromatography.
    Weckbecker G; Keppler DO
    Anal Biochem; 1983 Jul; 132(2):405-12. PubMed ID: 6625174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired ganglioside synthesis in rat liver after D-galactosamine administration in vivo.
    Rupprecht E; Hans C; Leonard G; Decker K
    Biochim Biophys Acta; 1976 Oct; 450(1):45-56. PubMed ID: 974155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 29. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.
    Rasenack U; Grün M; Liehr H
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):29-35. PubMed ID: 1119301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping.
    Keppler DO
    Cancer Res; 1977 Mar; 37(3):911-7. PubMed ID: 189918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)].
    Barbarino F; Suciu A; Cotutiu C; Ban A
    Wien Klin Wochenschr; 1977 Feb; 89(3):90-5. PubMed ID: 189515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the mechanism of action of galactosamine: different response to D-galactosamine of rat liver during development.
    Reutter W; Bauer C; Lesch R
    Naturwissenschaften; 1970 Dec; 57(12):674-5. PubMed ID: 5531365
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of rat alpha2 macroferoprotein (alphaMFP), an acute phase globulin, on galactosamine hepatitis.
    van Gool J; Boers W; de Nie I
    Exp Mol Pathol; 1978 Oct; 29(2):228-40. PubMed ID: 80330
    [No Abstract]   [Full Text] [Related]  

  • 40. Aggravating and protecting effects of triton and corticosteroids in galactosamine-induced hepatitis.
    Grases PJ; Lesch R; Stein U; Heissmeyer H; Reutter W
    G E N; 1972; 27(1):77-89. PubMed ID: 4632028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.